Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Financing › Details

Therachon–France (govt): investment, 201905 existing investors Bpifrance + Inserm Transfert Initiative

 

Period Period 2019-05-08 � 2019-05-08
  Successor Therachon–Pfizer: investment, 201905–201907 acquisition 100% $340m upfront + $470m milestones excl apraglutide development program
Organisations Money taker Therachon Holding AG
  Group Pfizer (Group)
  Money source Inserm Transfert Initiative (ITI)
  Group France (govt)
Products Product TA-46 (Therachon / Pfizer)
  Product 2 business development (state/region)
     

   
Record changed: 2019-05-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Pfizer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top